Former Rep Claims Purdue Offered Incentives to Sell More OxyContin
Former Rep Claims Purdue Offered Incentives to Sell More OxyContin
Former Rep Claims Purdue Offered Incentives to Sell More OxyContin
When is One Pill Too Many, Ten Pills Not Enough?
IV Tylenol No Better than Pills, Not Helping Crisis
Massachusetts Joins Fight Against Purdue, Names Owners in Lawsuit
Dean’s Double Life Recounted at Hearing Regarding Medical License
Addiction Call Centers Probed by Congress
The U.S. Food and Drug Administration issued a Monday alert over five deaths related to intragastric balloons. Intragastric balloons—used in the treatment of obesity—have so far been linked to a dozen fatalities worldwide. A nominally invasive device, the balloons encourage weight loss by taking up space in a patient’s stomach. Inserted through an individual’s mouth,
Minnesota Files Lawsuit Against Drug Company for Pain Reliever
Multiple Small Illinois Towns File Lawsuit Against Drug Company
Doctor Lived “Lavish” Lifestyle from Unnecessary Treatments